Argenx Se (ARGX) Assets Growth (1y) (2016 - 2026)
Argenx Se (ARGX) Assets Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.81% |
| Dec 31, 2025 | 39.99% |
| Jun 30, 2025 | 49.60% |
| Dec 31, 2024 | 36.55% |
| Jun 30, 2024 | 50.18% |
| Dec 31, 2023 | 44.93% |
| Jun 30, 2023 | -1.71% |
| Dec 31, 2022 | 9.96% |
| Jun 30, 2022 | 1.13% |
| Dec 31, 2021 | 34.83% |
| Jun 30, 2021 | 39.61% |
| Dec 31, 2020 | 29.61% |
| Jun 30, 2020 | 100.41% |
| Dec 31, 2019 | 147.79% |
| Jun 30, 2019 | 121.02% |
| Dec 31, 2018 | 22.97% |
| Jun 30, 2018 | 94.09% |
| Dec 31, 2017 | 250.67% |
| Dec 31, 2016 | 130.13% |